Lusuardi M, Capelli A, Di Stefano A, Zaccaria S, Balbi B, Donner C F
Division of Pulmonary Disease, IRCCS (Institute for Care and Research), Scientific Institute of Rehabilitation, Salvatore Maugeri Foundation, Veruno (NO) I-28010, Italy.
Respir Med. 2003 Nov;97(11):1205-10. doi: 10.1016/s0954-6111(03)00231-2.
Outpatients with tracheostomy can be managed with a low risk for severe airways infections despite colonization with pathogenic bacteria. No studies have been focused on chronic obstructive pulmonary disease (COPD), a condition known for recurrent exacerbations. The aim of our study was to verify whether at follow-up in tracheostomized COPD versus other disease outpatients, persistent P. aeruginosa colonization may influence the rate and treatment of lower respiratory tract infections (LRTI) or hospital admissions. Thirty-nine outpatients were considered: 24 were affected by COPD (age 66, 54-78 years, mean, range), 15 by restrictive lung disease (RLD) (57, 41-72 years). During an 18-month follow-up the number of LRTIs were recorded. Bacterial identifications were assessed at baseline and every month for 6 months in bronchial aspirates. The number of LRTI per patient was not significantly different between COPD [37, 1(0-6)] and RLD [18, 1(0-5)], [total, median (range)]. Persistent P. aeruginosa colonized 18 COPD (75%), 12 RLD patients (86%) and was not associated with an increased number of LRTI: 1(0-6) and 1(0-2), respectively. There were no differences in the number of hospital admissions: COPD 0(0-2), RLD 1(0-1), with a significant decrease versus before tracheostomy (P < 0.001). In conclusion, the rate of LRTI and hospital admissions in COPD outpatients with chronic tracheostomy was low, similar to non-COPD patients and independent of P. aeruginosa colonization.
尽管气管造口术门诊患者存在病原菌定植,但仍可在低严重气道感染风险下进行管理。目前尚无针对慢性阻塞性肺疾病(COPD)的研究,COPD是以反复发作为特征的疾病。我们研究的目的是验证在气管造口的COPD门诊患者与其他疾病门诊患者的随访中,铜绿假单胞菌持续定植是否会影响下呼吸道感染(LRTI)的发生率和治疗或住院情况。研究纳入了39例门诊患者:24例患有COPD(年龄66岁,范围54 - 78岁,均值),15例患有限制性肺疾病(RLD)(57岁,范围41 - 72岁)。在18个月的随访期间记录LRTI的发生次数。在基线时以及随后6个月每月对支气管吸出物进行细菌鉴定评估。COPD组[37次,中位数1(范围0 - 6)]和RLD组[18次,中位数1(范围0 - 5)] [总计,中位数(范围)]每位患者的LRTI次数无显著差异。持续定植铜绿假单胞菌的患者中,COPD有18例(75%),RLD有12例(86%),且与LRTI次数增加无关:分别为1(0 - 6)和1(0 - 2)。住院次数无差异:COPD为0(0 - 2),RLD为1(0 - 1),与气管造口术前相比显著减少(P < 0.001)。总之,慢性气管造口的COPD门诊患者的LRTI发生率和住院率较低,与非COPD患者相似,且与铜绿假单胞菌定植无关。